LWA
IRWD icon

Lenox Wealth Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Lenox Wealth Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-199
Closed -$3K – 420
2017
Q3 		$3K Buy
+199
New +$2.74K ﹤0.01% 111

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lenox Wealth Advisors's IRWD Position: Q4 2017 in Review

Lenox Wealth Advisors sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2017, closing a stake of 199 shares — an estimated $3K sold.

Lenox Wealth Advisors first reported a position in IRWD in Q3 2017 and held it in 1 quarter. The position peaked at $3K in Q3 2017. 158 funds tracked by Wall St. Rank hold IRWD as of Q4 2017.

  • Lenox Wealth Advisors reported no remaining Ironwood Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Lenox Wealth Advisors sold 199 Ironwood Pharmaceuticals shares in Q4 2017, an estimated $3K.
  • Lenox Wealth Advisors first reported a position in Ironwood Pharmaceuticals in Q3 2017 and held it in 1 quarter.
  • Lenox Wealth Advisors's Ironwood Pharmaceuticals position peaked at $3K in Q3 2017.
  • 158 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2017.

Based on Lenox Wealth Advisors's 13F filing for Q4 2017, filed 29 Jan 2018.